M&A / Deals Merck KGaA acquires JSR chromatography business Pharmaceutical Business ReviewThis follows the company's signing of a definitive agreement in October 2025 to acquire the business.M&A / DealsRead full story pharminent April 2, 2026 (Last updated: April 2, 2026) Pharmaceutical Business Review This follows the company’s signing of a definitive agreement in October 2025 to acquire the business. M&A / DealsRead full story Post navigation Previous: Biocytogen and Sihuan partner to advance new therapeutics for weight lossNext: Building What’s Next: Join Industry Leaders to Shape Access and Affordability Trends Ahead of Asembia AXS26 Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026